Search results
Recursion (RXRX) Stock Surges 191% in 3 Months: Here's Why
Zacks via Yahoo Finance· 10 months agoRecursion's (RXRX) shares rallied almost 191% over the past three months, owing to artificial...
Here is What to Know Beyond Why Recursion Pharmaceuticals, Inc. (RXRX) is a Trending Stock
Zacks via Yahoo Finance· 5 days agoRecursion Pharmaceuticals (RXRX) has been one of the stocks most watched by Zacks.com users lately....
Recursion Pharmaceuticals (RXRX) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance· 1 year agoRecursion Pharmaceuticals (RXRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing...
Recursion Pharmaceuticals (RXRX) Soars 7.4%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 5 months agoRecursion Pharmaceuticals (RXRX) saw its shares surge in the last session with trading volume being...
Recursion Pharmaceuticals Stock (NASDAQ:RXRX): Small Company, Big Future
TipRanks via Yahoo Finance· 5 months agoClinical-stage biotech company Recursion Pharmaceuticals (NASDAQ:RXRX) might be a relatively small...
Shareholders in Recursion Pharmaceuticals (NASDAQ:RXRX) have lost 46%, as stock drops 7.9% this past...
Simply Wall St. via Yahoo Finance· 2 years agoWhile not a mind-blowing move, it is good to see that the Recursion Pharmaceuticals, Inc....
Recursion Pharmaceuticals (NASDAQ:RXRX shareholders incur further losses as stock declines 4.7% this...
Simply Wall St. via Yahoo Finance· 1 year agoInvestors can approximate the average market return by buying an index fund. Active investors aim to...
Recursion (RXRX) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 3 weeks agoRecursion (RXRX) is expected to provide updates on its oncology and rare disease clinical-stage...
Recursion Pharmaceuticals (RXRX) Increases Yet Falls Behind Market: What Investors Need to Know
Zacks via Yahoo Finance· 3 weeks agoRecursion Pharmaceuticals (RXRX) closed the latest trading day at $8.84, indicating a +0.57% change...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) institutional owners may be pleased with recent gains...
Simply Wall St. via Yahoo Finance· 9 months agoKey Insights Given the large stake in the stock by institutions, Recursion Pharmaceuticals' stock...